Arch Biopartners ACHFF Stock
Arch Biopartners Price Chart
Arch Biopartners ACHFF Financial and Trading Overview
| Arch Biopartners stock price | 0.34 USD |
| Previous Close | 0.32 USD |
| Open | 0.33 USD |
| Bid | 0.36 USD x 1250000 |
| Ask | 0.38 USD x 1500000 |
| Day's Range | 0.33 - 0.38 USD |
| 52 Week Range | 0.29 - 1.42 USD |
| Volume | 30.9K USD |
| Avg. Volume | 25.26K USD |
| Market Cap | 25.14M USD |
| Beta (5Y Monthly) | 2.046 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACHFF Valuation Measures
| Enterprise Value | 27.39M USD |
| Trailing P/E | N/A |
| Forward P/E | -5.285714 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 159.00478 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 173.296 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Arch Biopartners Stock Price History
| Beta (5Y Monthly) | 2.046 |
| 52-Week Change | -71.96% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 1.42 USD |
| 52 Week Low | 0.29 USD |
| 50-Day Moving Average | 0.35 USD |
| 200-Day Moving Average | 0.72 USD |
ACHFF Share Statistics
| Avg. Volume (3 month) | 25.26K USD |
| Avg. Daily Volume (10-Days) | 20.32K USD |
| Shares Outstanding | 67.93M |
| Float | 52.33M |
| Short Ratio | N/A |
| % Held by Insiders | 19.17% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:3 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | September 30, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1481.29% |
| Gross Margin | -284.90% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -524.026% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 158.08K USD |
| Revenue Per Share (ttm) | 0.002 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -450368 USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -2695823 USD |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.16K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 2.63M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.007 |
| Book Value Per Share (mrq) | -0.03917592 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1530966 USD |
| Levered Free Cash Flow (ttm) | -761342 USD |
Profile of Arch Biopartners
| Country | United States |
| State | ON |
| City | Toronto |
| Address | 545 King Street West |
| ZIP | M5V 1M1 |
| Phone | 647-428-7031 |
| Website | https://www.archbiopartners.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Arch Biopartners Inc., together with its subsidiaries, engages in the development of novel drugs for acute kidney injury and organ damage in Canada. It focuses on developing its lead drug candidate LSALT Peptide, which is in Phase 2 trials to treat inflammation related acute kidney injury experienced by patients undergoing on-pump (bypass) cardiac surgery; and cilastatin to prevent toxin related acute kidney injury via dipeptidase-1. The company also develops CKD Platform, therapeutics targeting chronic kidney disease. Arch Biopartners Inc. is based in Toronto, Canada.
Q&A For Arch Biopartners Stock
What is a current ACHFF stock price?
Arch Biopartners ACHFF stock price today per share is 0.34 USD.
How to purchase Arch Biopartners stock?
You can buy ACHFF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Arch Biopartners?
The stock symbol or ticker of Arch Biopartners is ACHFF.
Which industry does the Arch Biopartners company belong to?
The Arch Biopartners industry is Biotechnology.
How many shares does Arch Biopartners have in circulation?
The max supply of Arch Biopartners shares is 67.93M.
What is Arch Biopartners Price to Earnings Ratio (PE Ratio)?
Arch Biopartners PE Ratio is now.
What was Arch Biopartners earnings per share over the trailing 12 months (TTM)?
Arch Biopartners EPS is -0.03 USD over the trailing 12 months.
Which sector does the Arch Biopartners company belong to?
The Arch Biopartners sector is Healthcare.